Saturn V Capital Management LP
CIK 1964437 · Holdings on Dec 31, 2023 · First reported Feb 14, 2024
Top ten holdings
Q4 2023- CYTK14.32%
- CRNX10.72%
- KALV8.48%
- ARGX7.45%
- CBAY6.78%
- ASND6.35%
- AMLX6.19%
- ANAB5.45%
- BMRN4.40%
- SNDX4.29%
Share classes counted separately74.43%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- CYTKWeight increased · +8.21 pp6.11% → 14.32%Shares -47.02K (-9.50%)
- COGTWeight decreased · -5.55 pp7.25% → 1.70%Shares -1.02M (-57.38%)
- ARGXWeight increased · +5.38 pp2.07% → 7.45%Shares +41.10K (+407.99%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 23
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | CYTKCYTOKINETICS INCCOM NEW View history and evidence | $37.42M | 14.32% | 448.14K shares | 6.11% → 14.32%+8.21 pp -47.02K (-9.50%) | Reduced | ↗▾ |
| 02 | CRNXCRINETICS PHARMACEUTICALS IN View history and evidence | $28.01M | 10.72% | 787.13K shares | 14.02% → 10.72%-3.30 pp -339.45K (-30.13%) | Reduced | ↗▾ |
| 03 | KALVKALVISTA PHARMACEUTICALS INC View history and evidence | $22.14M | 8.48% | 1.81M shares | 7.30% → 8.48%+1.18 pp -2.68K (-0.15%) | Reduced | ↗▾ |
| 04 | ARGXARGENX SE - ADRSPONSORED ADR View history and evidence | $19.47M | 7.45% | 51.17K shares | 2.07% → 7.45%+5.38 pp +41.10K (+407.99%) | Added | ↗▾ |
| 05 | CBAYCYMABAY THERAPEUTICS INC View history and evidence | $17.72M | 6.78% | 750.25K shares | 7.02% → 6.78%-0.24 pp -374.21K (-33.28%) | Reduced | ↗▾ |
| 06 | ASNDASCENDIS PHARMA A/SSPONSORED ADR View history and evidence | $16.60M | 6.35% | 131.76K shares | 4.41% → 6.35%+1.94 pp +19.29K (+17.15%) | Added | ↗▾ |
| 07 | AMLXAMYLYX PHARMACEUTICALS INC View history and evidence | $16.18M | 6.19% | 1.10M shares | 6.79% → 6.19%-0.60 pp +213.13K (+24.05%) | Added | ↗▾ |
| 08 | ANABANAPTYSBIO INC View history and evidence | $14.23M | 5.45% | 664.28K shares | 4.34% → 5.45%+1.11 pp +87.17K (+15.11%) | Added | ↗▾ |
| 09 | BMRNBIOMARIN PHARMACEUTICAL INC View history and evidence | $11.49M | 4.40% | 119.19K shares | 4.06% → 4.40%+0.34 pp +9.50K (+8.66%) | Added | ↗▾ |
| 10 | SNDXSYNDAX PHARMACEUTICALS INC View history and evidence | $11.21M | 4.29% | 518.80K shares | 4.91% → 4.29%-0.62 pp -289.17K (-35.79%) | Reduced | ↗▾ |
Options overlay 0
No options reported this quarter.
Exited positions 3
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| SRPT SAREPTA THERAPEUTICS INC | Non-derivative | -118,401 | -$14.35M | SEC filing ↗ | SEC filing ↗ |
| HZNP HORIZON THERAPEUTICS PLC | Non-derivative | -111,045 | -$12.85M | SEC filing ↗ | SEC filing ↗ |
| BCRX BIOCRYST PHARMACEUTICALS INC | Non-derivative | -982,458 | -$6.96M | SEC filing ↗ | SEC filing ↗ |
3 / 3 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1964437 · Period 2023-12-31
Data loaded 2026-09-23 · First reported 2024-02-14
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 261248668
}Take these holdings further.
This page includes 23 of 23 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 23 of 23 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1964437","quarter":"2023Q4","page_size":100}
get_institutional_manager_history
{"cik":"1964437","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.